首页|"幽门螺杆菌感染治疗新路径"势在必行

"幽门螺杆菌感染治疗新路径"势在必行

扫码查看
幽门螺杆菌的治疗目前主要依赖抗生素.在幽门螺杆菌感染率较高的中国地区,合理应用抗生素对于提高治疗效果和控制耐药性具有重要意义.本文从幽门螺杆菌治疗中抗生素使用的现存问题及注意事项出发,探讨"治疗共识"与"个体化治疗"的合理结合,以及在药物疗效与安全性之间的平衡策略.旨在阐明合理使用抗生素的重要性,并提出探索"幽门螺杆菌感染治疗新路径"的必要性.
A new pathway for treating Helicobacter pylori infections:a pressing need
Given that the treatment of Helicobacter pylori primarily relies on antibiotics,rational use of antibiotics is crucial for addressing the high infection rate in China.This article explores key issues and considerations in the current use of antibiotics for Helicobacter pylori treatment,focusing on the balance between standardized guidelines and individ-ualized treatment,as well as the management of drug efficacy and safety.The aim is to highlight the importance of rational antibiotic use in Helicobacter pylori therapy and underscore the urgent need to explore new pathways for manag-ing Helicobacter pylori infection.

Helicobacter pyloriAntibioticsIndividualized treatment

胡伏莲

展开 >

北京大学第一医院消化内科,北京 100034

幽门螺杆菌 抗生素 个体化治疗

2024

胃肠病学和肝病学杂志
郑州大学

胃肠病学和肝病学杂志

CSTPCD
影响因子:1.029
ISSN:1006-5709
年,卷(期):2024.33(12)